This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spriggs, M. K.
Right arrow Articles by Cohen, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spriggs, M. K.
Right arrow Articles by Cohen, J. I.

 Previous Article  |  Next Article 

J. Virol., 08 1996, 5557-5563, Vol 70, No. 8
Copyright © 1996, American Society for Microbiology

The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation

MK Spriggs, RJ Armitage, MR Comeau, L Strockbine, T Farrah, B Macduff, D Ulrich, MR Alderson, J Mullberg and JI Cohen
Immunex Corporation, Seattle, Washington 98101, USA.

The Epstein-Barr virus BZLF2 gene encodes a glycoprotein that associates with gH and gL and facilitates the infection of B lymphocytes. In order to determine whether the BZLF2 protein recognizes a B-cell-specific surface antigen, a soluble protein containing the extracellular portion of the BZLF2 protein linked to the Fc portion of human immunoglobulin G1 (BZLF2.Fc) was expressed from mammalian cells. BZLF2.Fc was used in an expression cloning system and found to bind to a beta-chain allele of the HLA-DR locus of the class II major histocompatibility complex (MHC). Analysis of amino- and carboxy- terminal deletion mutants of the BZLF2.Fc protein indicated that the first 90 amino acids of BZLF2.Fc are not required for HLA-DR beta-chain recognition. Site-directed mutagenesis of an HLA-DR beta-chain cDNA and subsequent immunoprecipitation of expressed mutant beta-chain proteins using BZLF2.Fc indicated that the beta1 domain, which participates in the formation of peptide binding pockets, is required for BZLF2.Fc recognition. The addition of BZLF2.Fc to sensitized peripheral blood mononuclear cells in vitro abolished their proliferative response to antigen and inhibited cytokine-dependent cytotoxic T-cell generation in mixed lymphocyte cultures. Flow-cytometric analysis of Akata cells induced to express late Epstein-Barr virus antigens indicated that expression of BZLF2 did not result in reduced surface expression levels of MHC class II. The ability of BZLF2.Fc to bind to the HLA-DR beta chain suggests that the BZLF2 protein may interact with MHC class II on the surfaces of B cells.


This article has been cited by other articles:

  • Sorem, J., Jardetzky, T. S., Longnecker, R. (2009). Cleavage and Secretion of Epstein-Barr Virus Glycoprotein 42 Promote Membrane Fusion with B Lymphocytes. J. Virol. 83: 6664-6672 [Abstract] [Full Text]  
  • Reimer, J. J., Backovic, M., Deshpande, C. G., Jardetzky, T., Longnecker, R. (2009). Analysis of Epstein-Barr Virus Glycoprotein B Functional Domains via Linker Insertion Mutagenesis. J. Virol. 83: 734-747 [Abstract] [Full Text]  
  • Dry, I., Haig, D. M., Inglis, N. F., Imrie, L., Stewart, J. P., Russell, G. C. (2008). Proteomic Analysis of Pathogenic and Attenuated Alcelaphine Herpesvirus 1. J. Virol. 82: 5390-5397 [Abstract] [Full Text]  
  • Young, K. A., Chen, X. S., Holers, V. M., Hannan, J. P. (2007). Isolating the Epstein-Barr Virus gp350/220 Binding Site on Complement Receptor Type 2 (CR2/CD21). J. Biol. Chem. 282: 36614-36625 [Abstract] [Full Text]  
  • Kirschner, A. N., Lowrey, A. S., Longnecker, R., Jardetzky, T. S. (2007). Binding-Site Interactions between Epstein-Barr Virus Fusion Proteins gp42 and gH/gL Reveal a Peptide That Inhibits both Epithelial and B-Cell Membrane Fusion. J. Virol. 81: 9216-9229 [Abstract] [Full Text]  
  • Hutt-Fletcher, L. M. (2007). Epstein-Barr Virus Entry. J. Virol. 81: 7825-7832 [Full Text]  
  • Wiertz, E. J., Devlin, R., Collins, H. L., Ressing, M. E. (2007). Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation. J. Virol. 81: 4389-4396 [Full Text]  
  • Hart, J., Ackermann, M., Jayawardane, G., Russell, G., Haig, D. M., Reid, H., Stewart, J. P. (2007). Complete sequence and analysis of the ovine herpesvirus 2 genome. J. Gen. Virol. 88: 28-39 [Abstract] [Full Text]  
  • Kirschner, A. N., Omerovic, J., Popov, B., Longnecker, R., Jardetzky, T. S. (2006). Soluble Epstein-Barr Virus Glycoproteins gH, gL, and gp42 Form a 1:1:1 Stable Complex That Acts Like Soluble gp42 in B-Cell Fusion but Not in Epithelial Cell Fusion. J. Virol. 80: 9444-9454 [Abstract] [Full Text]  
  • Wu, L., Borza, C. M., Hutt-Fletcher, L. M. (2005). Mutations of Epstein-Barr Virus gH That Are Differentially Able To Support Fusion with B Cells or Epithelial Cells. J. Virol. 79: 10923-10930 [Abstract] [Full Text]  
  • Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Keating, S., Gomez, R., Franken, K. L. M. C., Ottenhoff, T. H. M., Spriggs, M., Schumacher, T. N., Hutt-Fletcher, L. M., Rowe, M., Wiertz, E. J. H. J. (2005). Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion. J. Virol. 79: 841-852 [Abstract] [Full Text]  
  • McShane, M. P., Longnecker, R. (2004). Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins. Proc. Natl. Acad. Sci. USA 101: 17474-17479 [Abstract] [Full Text]  
  • Stewart, J. P., Silvia, O. J., Atkin, I. M. D., Hughes, D. J., Ebrahimi, B., Adler, H. (2004). In Vivo Function of a Gammaherpesvirus Virion Glycoprotein: Influence on B-Cell Infection and Mononucleosis. J. Virol. 78: 10449-10459 [Abstract] [Full Text]  
  • Silva, A. L., Omerovic, J., Jardetzky, T. S., Longnecker, R. (2004). Mutational Analyses of Epstein-Barr Virus Glycoprotein 42 Reveal Functional Domains Not Involved in Receptor Binding but Required for Membrane Fusion. J. Virol. 78: 5946-5956 [Abstract] [Full Text]  
  • Borza, C. M., Morgan, A. J., Turk, S. M., Hutt-Fletcher, L. M. (2004). Use of gHgL for Attachment of Epstein-Barr Virus to Epithelial Cells Compromises Infection. J. Virol. 78: 5007-5014 [Abstract] [Full Text]  
  • de Lima, B. D., May, J. S., Stevenson, P. G. (2004). Murine Gammaherpesvirus 68 Lacking gp150 Shows Defective Virion Release but Establishes Normal Latency In Vivo. J. Virol. 78: 5103-5112 [Abstract] [Full Text]  
  • Shumilla, J. A., Lacaille, V., Hornell, T. M. C., Huang, J., Narasimhan, S., Relman, D. A., Mellins, E. D. (2004). Bordetella pertussis Infection of Primary Human Monocytes Alters HLA-DR Expression. Infect. Immun. 72: 1450-1462 [Abstract] [Full Text]  
  • Katzman, R. B., Longnecker, R. (2003). Cholesterol-dependent infection of Burkitt's lymphoma cell lines by Epstein-Barr virus. J. Gen. Virol. 84: 2987-2992 [Abstract] [Full Text]  
  • Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Gomez, R., Heemskerk, B., Toebes, M., Mullen, M. M., Jardetzky, T. S., Longnecker, R., Schilham, M. W., Ottenhoff, T. H. M., Neefjes, J., Schumacher, T. N., Hutt-Fletcher, L. M., Wiertz, E. J. H. J. (2003). Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl. Acad. Sci. USA 100: 11583-11588 [Abstract] [Full Text]  
  • Yilla, M., Hickman, C., McGrew, M., Meade, E., Bellini, W. J. (2003). Edmonston Measles Virus Prevents Increased Cell Surface Expression of Peptide-Loaded Major Histocompatibility Complex Class II Proteins in Human Peripheral Monocytes. J. Virol. 77: 9412-9421 [Abstract] [Full Text]  
  • McShane, M. P., Mullen, M. M., Haan, K. M., Jardetzky, T. S., Longnecker, R. (2003). Mutational Analysis of the HLA Class II Interaction with Epstein-Barr Virus Glycoprotein 42. J. Virol. 77: 7655-7662 [Abstract] [Full Text]  
  • Mori, Y., Yang, X., Akkapaiboon, P., Okuno, T., Yamanishi, K. (2003). Human Herpesvirus 6 Variant A Glycoprotein H-Glycoprotein L-Glycoprotein Q Complex Associates with Human CD46. J. Virol. 77: 4992-4999 [Abstract] [Full Text]  
  • Neuhierl, B., Feederle, R., Hammerschmidt, W., Delecluse, H. J. (2002). Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc. Natl. Acad. Sci. USA 99: 15036-15041 [Abstract] [Full Text]  
  • Rivailler, P., Cho, Y.-g., Wang, F. (2002). Complete Genomic Sequence of an Epstein-Barr Virus-Related Herpesvirus Naturally Infecting a New World Primate: a Defining Point in the Evolution of Oncogenic Lymphocryptoviruses. J. Virol. 76: 12055-12068 [Abstract] [Full Text]  
  • Trgovcich, J., Johnson, D., Roizman, B. (2002). Cell Surface Major Histocompatibility Complex Class II Proteins Are Regulated by the Products of the {gamma}134.5 and UL41 Genes of Herpes Simplex Virus 1. J. Virol. 76: 6974-6986 [Abstract] [Full Text]  
  • Li, L., Liu, D., Hutt-Fletcher, L., Morgan, A., Masucci, M. G., Levitsky, V. (2002). Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 99: 3725-3734 [Abstract] [Full Text]  
  • Birkmann, A., Mahr, K., Ensser, A., Titgemeyer, F., Fleckenstein, B., Neipel, F. (2001). Cell Surface Heparan Sulfate Is a Receptor for Human Herpesvirus 8 and Interacts with Envelope Glycoprotein K8.1. J. Virol. 75: 11583-11593 [Abstract] [Full Text]  
  • Maruo, S., Yang, L., Takada, K. (2001). Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J. Gen. Virol. 82: 2373-2383 [Abstract] [Full Text]  
  • Janz, A., Oezel, M., Kurzeder, C., Mautner, J., Pich, D., Kost, M., Hammerschmidt, W., Delecluse, H.-J. (2000). Infectious Epstein-Barr Virus Lacking Major Glycoprotein BLLF1 (gp350/220) Demonstrates the Existence of Additional Viral Ligands. J. Virol. 74: 10142-10152 [Abstract] [Full Text]  
  • Haan, K. M., Longnecker, R. (2000). Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection. Proc. Natl. Acad. Sci. USA 10.1073/pnas.160171697v1 [Abstract] [Full Text]  
  • Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M., Hutt-Fletcher, L. M. (2000). Epstein-Barr Virus gH Is Essential for Penetration of B Cells but Also Plays a Role in Attachment of Virus to Epithelial Cells. J. Virol. 74: 6324-6332 [Abstract] [Full Text]  
  • Haan, K. M., Kwok, W. W., Longnecker, R., Speck, P. (2000). Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor. J. Virol. 74: 2451-2454 [Abstract] [Full Text]  
  • Mullberg, J, Hsu, M., Rauch, C., Gerhart, M., Kaykas, A, Cosman, D (1999). The R27080 glycoprotein is abundantly secreted from human cytomegalovirus-infected fibroblasts. J. Gen. Virol. 80: 437-440 [Abstract]  
  • Bejarano, M.T., Masucci, M.G. (1998). Interleukin-10 Abrogates the Inhibition of Epstein-Barr Virus-Induced B-Cell Transformation by Memory T-Cell Responses. Blood 92: 4256-4262 [Abstract] [Full Text]  
  • Borza, C. M., Hutt-Fletcher, L. M. (1998). Epstein-Barr Virus Recombinant Lacking Expression of Glycoprotein gp150 Infects B Cells Normally but Is Enhanced for Infection of Epithelial Cells. J. Virol. 72: 7577-7582 [Abstract] [Full Text]  
  • Wang, X., Kenyon, W. J., Li, Q., Mullberg, J., Hutt-Fletcher, L. M. (1998). Epstein-Barr Virus Uses Different Complexes of Glycoproteins gH and gL To Infect B Lymphocytes and Epithelial Cells. J. Virol. 72: 5552-5558 [Abstract] [Full Text]  
  • Strockbine, L. D., Cohen, J. I., Farrah, T., Lyman, S. D., Wagener, F., DuBose, R. F., Armitage, R. J., Spriggs, M. K. (1998). The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor. J. Virol. 72: 4015-4021 [Abstract] [Full Text]  
  • Wang, X., Hutt-Fletcher, L. M. (1998). Epstein-Barr Virus Lacking Glycoprotein gp42 Can Bind to B Cells but Is Not Able To Infect. J. Virol. 72: 158-163 [Abstract] [Full Text]  
  • Cohen, J. I. (1997). Epstein-Barr Virus and the Immune System: Hide and Seek. JAMA 278: 510-513 [Abstract]  
  • Haan, K. M., Longnecker, R. (2000). Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection. Proc. Natl. Acad. Sci. USA 97: 9252-9257 [Abstract] [Full Text]